Midgard Science
B

BioAscent

Newhouse, United Kingdom bioascent.com

From their website, Nov 2026

Work here? Claim this listing

About

BioAscent is a drug discovery CRO based in Newhouse, Scotland, UK. It provides integrated discovery services for biopharma customers, including assay development, screening, medicinal and synthetic chemistry, computational chemistry, protein production, structural biology, and compound management. The company also manages customer compound libraries and supports projects from target work through to preclinical and clinical candidates.

Services

  • De novo assay development

    Designs and develops new assays for drug discovery projects.

    Assays & in vitro testing

  • Assay optimisation and miniaturisation

    Optimises existing assays and scales them down for efficient screening.

    Assays & in vitro testing

  • Biochemical, biophysical and cellular assay development

    Develops bespoke biochemical, biophysical, and cellular assays for target interrogation and hit identification.

    Assays & in vitro testing

  • Target analysis & bespoke screening strategies

    Designs and interprets assay cascades and screening strategies for a target.

    Assays & in vitro testing

  • Compound screening

    Runs screening campaigns including HTS, MTS, fragment, focused, iterative, diversity-based and virtual screening.

    Assays & in vitro testing

  • Medicinal chemistry

    Designs and synthesises ligands through hit generation, hit-to-lead, and lead optimisation.

  • Synthetic chemistry

    Provides route design and tailored synthesis, including building blocks, multi-step synthesis, asymmetric synthesis, parallel synthesis, and reference molecules.

  • In silico discovery and AI

    Applies computational chemistry, CADD, cheminformatics, modelling, and data analysis to drug discovery projects.

  • Physicochemical profiling & DMPK

    Supports discovery DMPK work and connects medicinal chemistry with ADME and pharmacokinetic data.

    ADME, DMPK & toxicology

  • Protein production

    Provides bespoke protein expression, purification, and characterisation.

    Protein production

  • Surface plasmon resonance (SPR) & biophysics

    Measures biomolecular interactions and binding kinetics using SPR and related biophysical methods.

    Assays & in vitro testing

  • Structural biology

    Uses X-ray crystallography for target validation, hit validation, SAR support, and fragment screening.

    Assays & in vitro testing

  • Compound management

    Stores, manages, reformats, and ships compound libraries in liquid and solid formats.

  • In-house diversity, fragment & chemogenomic libraries

    Provides access to in-house diversity, fragment, and chemogenomic libraries for screening and phenotypic studies.

  • External library selection & sourcing

    Designs and sources custom screening libraries from supplier databases.

  • Mitochondrial biology

    Uses mitochondrial profiling assays to de-risk programs and assess mitochondrial liabilities.

    Assays & in vitro testing

  • Gpcr drug discovery

    Supports GPCR projects with assay development, screening, medicinal chemistry, in-silico methods, and integrated project delivery.

    Assays & in vitro testing

  • Accelerating CNS drug discovery

    Supports CNS drug optimisation with computational and chemistry approaches focused on blood-brain-barrier challenges.

  • Integrated drug discovery

    Combines biology, chemistry, computational, and compound management capabilities to support drug discovery projects from target to candidate.

  • Bespoke assay development

    Develops and optimises biochemical, biophysical, and cellular assays for hit identification, mechanistic profiling, and medicinal chemistry support.

    Assays & in vitro testing

  • Mitochondrial biology in drug discovery

    Uses translational mitochondrial assays to assess bioenergetic effects, mechanism of action, and mitochondrial liabilities.

    Assays & in vitro testing

  • CNS drug discovery

    Supports central nervous system drug discovery with computational, chemistry, and integrated optimisation approaches.

  • Biochemical, Biophysical & Cellular Assay Development

    Develops and validates assays for drug discovery programs across biochemical, biophysical, and cellular formats.

    Assays & in vitro testing

What to send
Protein samples · Compound libraries · Customer compounds · Target or structure information for custom library design · Compound libraries in liquid and solid formats

Capabilities

As they state on their website or in their listing.

Processes
Small molecule · Recombinant protein · SPR · HTS · Small molecules · ADME
Capacity
125K IP-free molecules · 86,000 compounds held as solid stock · Over 1.5 million compounds managed for customers · Libraries of up to 250k in size · 96-well plates · 384-well plates · 1536-well plates · Three individually housed, environmentally controlled -20°C stores · In-house diversity library of 125K IP-free molecules · 86,000 compounds also held as solid stock · Multiple HTS and fragment screens using libraries of up to 250k in size · Three individually housed environmentally controlled -20°C stores
7 more96, 384 and 1536-well plate formats · Libraries up to 250k in size · Over 100,000 screening plates · 96-well plate formats · 384-well plate formats · 1536-well plate formats · Three individually housed -20°C stores
Data supplied
NMR · LC-MS

Equipment

  • Biacore 8K
  • Seahorse XF
  • LC-MS
  • UPLC
  • SFC
  • NMR
  • Diamond Light Source synchrotron
  • Mosaic from Titian
  • Robotic systems
  • Surface plasmon resonance (SPR)

Industries served

  • Biotechnology
  • Pharmaceutical
  • Academia

Company

Type
CRO
Founded
2013

Locations

Based in
Newhouse, United Kingdom
Sites
Newhouse, United Kingdom
Serves
around the world, customers from around the world, global customers, partners

Contacts

Similar labs

Work here? Claim this listing